Groowe Groowe / Newsroom / ABBV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

prnewswire.com
ABBV

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight

prnewswire.com
ABBV QTTB HCWB NKTR LLY INCY PFE

Cancer & Antibody Conjugates Patent Landscape Analysis 2025: 3761 Patent Families - IP Trends, Including Time Evolution of Published Patents and Countries of Patent Filings

globenewswire.com
PFE BMY ABBV AZN GILD

AbbVie Declares Quarterly Dividend

prnewswire.com
ABBV

FNIH Biomarkers Consortium Study Shows “Clock Model” Blood Test Can Predict Onset of Alzheimer’s Symptoms Years in Advance

businesswire.com
ABBV JNJ BIIB

JAK Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 40+ Companies and 45+ Drugs by Company, Product Type, Development Stage, Administration Route, Molecule Type

globenewswire.com
LLY ABBV INCY

Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight

prnewswire.com
BMY ABBV REGN LLY PFE

Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research

prnewswire.com
TMO MRK BIO BIIB AMGN GILD REGN CRSP NTLA BMY ABBV AZN NVS PFE JNJ MRNA BNTX COR STEM ALGN EXAS MDLZ BHC CVS UNH CI CNC ELAN ZTS ISRG QRVO SWKS AVGO QCOM INTC MSFT GOOG AMZN IBM ORCL CRM ADBE NFLX DIS MCD SBUX KO PEP PG JPM BAC WFC C GS MS AXP V MA HD LOW COST TGT WMT BBY CMCSA VZ T XOM CVX SIRI UBER LYFT NVDA AMD MU AMAT LRCX ASML ADI TXN QGEN ILMN VRTX EDIT BEAM SRPT ACAD ALKS MDT SYK DHR GOOGL

U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs

globenewswire.com
BMY GILD JNJ SNY TAK AMGN AZN LLY MRK PFE REGN VRTX ABBV ALNY AMTX BIIB BMRN CRSP EXAS INCY IONS JAZZ NTLA PTC RGEN XOM

Conjunctivitis Market to Reach $61.6 Billion by 2033 Globally, at 13.8% CAGR: Allied Market Research

prnewswire.com
ABBV JNJ BHC NVS